Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 4 3Phase 3 2Phase NA 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 3

Conditions

Brain Neoplasms 2Seizures 1Glioma 1Epilepsy 1

Interventions

Saline Solution 6Dexmedetomidine 5Sodium Chloride 4Temozolomide 3Sevoflurane 3Propofol 3Methotrexate 3Levetiracetam 3trametinib 2perampanel 2dabrafenib 2Sugammadex 2Neuroimaging 2Methylphenidate 2Magnetic Resonance Spectroscopy 2Granulocyte-Macrophage Colony-Stimulating Factor 2Gentamicins 2Fluorescein 2Anesthesia, Inhalation 2trastuzumab deruxtecan 1trastuzumab biosimilar HLX02 1pembrolizumab 1pegvisomant 1olutasidenib 1naxitamab 1lorlatinib 1gadoterate meglumine 1gadobenic acid 1durvalumab 1dexketoprofen trometamol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Levetiracetam × CNS × Clear all
NCT03048084 2025-02-04

STING

Leiden University Medical Center

Phase 4 Recruiting
120 enrolled
CNS

Glioma

NCT02334722 2021-12-15

1 Week Versus 6 Weeks of Levetiracetam in Surgical Brain Tumor Patients

University of Florida

Phase 4 Completed
81 enrolled 10 charts
CNS

Brain Neoplasms, Seizures

NCT00571155 2009-08-20

Trial of Levetiracetam in Patients With Primary Brain Tumors and Symptomatic Seizures Who Undergo Surgery

University Hospital Tuebingen

Phase 4 Completed
30 enrolled
CNS

Brain Neoplasms, Epilepsy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡